Hemagen Diagnostics Performance
| HMGNDelisted Stock | USD 0.0001 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hemagen Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Hemagen Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Hemagen Diagnostics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -56 K |
Hemagen |
Hemagen Diagnostics Relative Risk vs. Return Landscape
If you would invest 0.01 in Hemagen Diagnostics on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Hemagen Diagnostics or generate 0.0% return on investment over 90 days. Hemagen Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Hemagen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hemagen Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemagen Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Hemagen Diagnostics, and traders can use it to determine the average amount a Hemagen Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HMGN |
Based on monthly moving average Hemagen Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemagen Diagnostics by adding Hemagen Diagnostics to a well-diversified portfolio.
Hemagen Diagnostics Fundamentals Growth
Hemagen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hemagen Diagnostics, and Hemagen Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hemagen Pink Sheet performance.
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 441.76 K | ||||
| Shares Outstanding | 15.5 M | ||||
| Price To Earning | (0.17) X | ||||
| Price To Sales | 0.1 X | ||||
| Revenue | 4.04 M | ||||
| EBITDA | (273.66 K) | ||||
| Cash And Equivalents | 66.29 K | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (358.69 K) | ||||
| Earnings Per Share | (0.06) X | ||||
| Total Asset | 2.44 M | ||||
| Retained Earnings | (26.68 M) | ||||
| Current Asset | 2.1 M | ||||
| Current Liabilities | 1.95 M | ||||
About Hemagen Diagnostics Performance
By examining Hemagen Diagnostics' fundamental ratios, stakeholders can obtain critical insights into Hemagen Diagnostics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Hemagen Diagnostics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 15 people.Things to note about Hemagen Diagnostics performance evaluation
Checking the ongoing alerts about Hemagen Diagnostics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hemagen Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hemagen Diagnostics is not yet fully synchronised with the market data | |
| Hemagen Diagnostics has some characteristics of a very speculative penny stock | |
| Hemagen Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.04 M. Net Loss for the year was (907.32 K) with profit before overhead, payroll, taxes, and interest of 1.61 M. | |
| Hemagen Diagnostics currently holds about 66.29 K in cash with (358.69 K) of positive cash flow from operations. |
- Analyzing Hemagen Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hemagen Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Hemagen Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hemagen Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hemagen Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hemagen Diagnostics' pink sheet. These opinions can provide insight into Hemagen Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Hemagen Pink Sheet
If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |